Clinical trials for Angina

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Angina. For all clinical trials, go to clinical trials search

This list shows clinical trials for Angina

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Angina
Title Recruitment status Location
A Randomized, Double-Blind, Placebo Controlled, Multicenter, Phase III Study of Rosuvastatin (CRESTOR) 20 mg in the Primary Prevention of Cardiovascular Events Among Subjects with Low Levels of LDL Cholesterol and Elevated Levels of C-Reactive Protein - JUPITER Not Recruiting United Kingdom
FondaparinUx Trial with UFH during Revascularization in Acute Coronary Syndromes (FUTURA) A prospective study evaluating the safety of two regimens of adjunctive intravenous UFH during PCI in high risk patients with UA/NSTEMI initially treated with subcutaneous fondaparinux and referred for early coronary angiography (OASIS 8) - OASIS 8 (FUTURA) Not Recruiting United Kingdom
A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome (ACS) Subjects with Unstable Angina/Non-ST-Elevation Myocardial Infarction (UA/NSTEMI) Who are Medically Managed - The TRILOGY ACS Study - Trilogy ACS Not Recruiting United Kingdom
Long-term (3 years) ophthalmic safety and cardiac efficacy and safety of ivabradine administered orally at the therapeutic doses (2.5/5/7.5 mg twice daily (b.i.d.)) on top of anti-anginal background therapy, to patients with chronic stable angina pectoris. Not Recruiting United Kingdom
Estudio comparativo de Prasugrel frente a Clopidogrel en pacientes con un síndrome coronario agudo (SCA) con angina inestable / infarto de miocardio sin elevación del ST (UA/NSTEMI) que reciben tratamiento médico – Estudio TRILOGY ACS A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome (ACS) Subjects with Unstable Angina/Non-ST-Elevation Myocardial Infarction (UA/NSTEMI) Who are Medically Managed - The TRILOGY ACS Study - Trilogy ACS Not Recruiting United Kingdom
Randomized, multinational, double-blind study, comparing a high loading dose regimen of clopidogrel versus standard dose in patients with unstable angina or myocardial infarction managed with an early invasive strategy - CURRENT Not Recruiting United Kingdom
Evaluation of the anti-anginal efficacy and safety of oral administration of ivabradina compared to placebo on top of a background therapy with atenolol in patients with stable angina pectoris. A 4-month randomised double-blind parallel-gourp international multicentre study. Not Recruiting United Kingdom
Randomized, double-blind, triple-dummy trial to compare the efficacy of otamixaban with Unfractionated Heparin + eptifibatide, in patients with Unstable angina/Non ST segment Elevation Myocardial infarction scheduled to undergo an early invasive strategy - TAO Not Recruiting United Kingdom
A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects Not Recruiting United Kingdom
Long-term (3 years) ophthalmic safety and cardiac efficacy and safety of ivabradine administered orally at the therapeutic doses (2.5/5/7.5 mg b.i.d.) on top of anti-anginal background therapy, to patients with chronic stable angina pectoris. An international, double-blind placebo controlled study. Not Recruiting United Kingdom

Page last reviewed: 29/09/2011

Next review due: 29/09/2013